top of page

CO-DILAVASC

CodilavascLogoMin-01.png

FORMULATION:
Each film-coated tablet contains:
Losartan potassium ..............................................................50 mg
Amlodipine (as Besilate) ........................................................5 mg


INDICATIONS:
Losartan potassium/Amlodipine besilate is indicated for the treatment of hypertension, angina pectoris & mild to moderate hypertension, alone or in combination with other antihypertensives.


DOSAGE AND ADMINISTRATION:
The usual starting and maintenance dose is one tablet once daily for most patients. The dose may be increase to 2 tablets once daily. A lower dose should be considered for patients with a history of hepatic impairment. Or as prescribed by the Physician.


PHARMACOLOGICAL CLASSIFICATION:
VasodiIators, hypotensive medicines.


PHARMACOKINETICS:
Absorption: Amlodipine: Plasma levels peak 6-12 hr after oral administration; absolute bioavailability is estimated to be 64-90%. Losartan: Well absorbed; undergoes substantial 1st pass metabolism by CYP450 enzymes; systemic
bioavailability is about 33%; about 14% of an oral dose is converted to active metabolites.
Distribution: Amlodipine: 93% bound to plasma proteins. Losartan and its active metabolites: Highly bound to plasma proteins, mainly albumin.
Metabolism: Amlodipine: About 90% converted to inactive metabolites hepatically. Losartan is metabolised to an active carboxylic acid metabolite E-3174 (EXP-3174), which has greater pharmacological activity than losartan; some inactive metabolites are also formed.
Excretion: Amlodipine: 10% of parent compound and 60% of the metabolites are removed in the urine; elimination from the plasma is biphasic with terminal half-life of about 30-50 hr. Losartan and its active metabolites: Biliary excretion; terminal half-life: About 2 hr (Losartan) and 6-9 hr (metabolites).


CONTRAINDICATIONS:
Losartan potassium/Amlodipine besilate during pregnancy and lactation is contraindicated Safety and efficacy has not been established in children. Hypersensitivity to any of the ingredients & dihydropyridines.

 

CodilavascNew.png

CAUTION:
Foods, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.


STORAGE CONDITION:
Store at temperatures not exceeding 30°C.


KEEP ALL MEDICINES OUT OF REACH OF CHILDREN.


AVAILABILITY:
Alu/ Clear PVC Blister Pack of 10’s (Box of 100’s)

​

Exclusively Distributed by:
PRIMERA PHARMA CORP.

#61-C Times St., cor. Dalisay
West Triangle Homes, Quezon City

​

Manufactured by:
STALLION LABORATORIES PVT. LTD.

C1B, 305/2 &3, G.I.D.C., Kerala (Bavla),
Dist.: Ahmedabad 382 220, Gujarat, India

​

Imported and Distributed by:
AMBICA INTERNATIONAL CORPORATION

No.9 Amsterdam Extension, Merville Park Subdivision,
Parañaque City, Philippines

bottom of page